◆Genexine=Completion of Phase 1/2a clinical trial for COVID-19 vaccine (GX-19)


◆Joycity=Change to sole CEO system with CEO Jo Sung-won


◆TCK=Change to co-CEO system with Masafumi Tsuji and Hiroshi Takahashi


◆Tuksu Construction=Signed construction contract worth 19.9 billion KRW with SK Construction



◆Corentec=Acquired patent rights for tibial osteotomy guide assembly


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing